LYMPHOCYTIC LEUKEMIA, CHRONIC
Clinical trials for LYMPHOCYTIC LEUKEMIA, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new LYMPHOCYTIC LEUKEMIA, CHRONIC trials appear
Sign up with your email to follow new studies for LYMPHOCYTIC LEUKEMIA, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for tough blood cancers after other treatments fail
Disease control CompletedThis study tested a new drug called mosunetuzumab, both alone and combined with another drug (atezolizumab), for people with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukemia that had come back or stopped responding to prior treatments. The main goals were to find safe …
Matched conditions: LYMPHOCYTIC LEUKEMIA, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug combo shows promise in controlling blood cancer for frail patients
Disease control CompletedThis completed Phase 3 trial tested two different drug combinations for people with chronic lymphocytic leukemia (CLL) who also had other health problems and needed treatment for the first time. It compared a newer combination (obinutuzumab + venetoclax) against an older standard…
Matched conditions: LYMPHOCYTIC LEUKEMIA, CHRONIC
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC